Neil Kumar - CEO and President, Director at BridgeBio Pharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and President, Director
Stock Symbol
BBIO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Neil Kumar - trading volume in the past year for BridgeBio Pharma, Inc.

Holdings reported by Neil Kumar for BridgeBio Pharma, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 4,897,443 $152 M $31.04 May 16, 2024 Direct
Common Stock 1,012,722 $31.4 M $31.04 May 16, 2024 By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Common Stock 995,686 $30.9 M $31.04 May 16, 2024 By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Restricted Stock Units 293,989 $9.13 M $31.04 May 16, 2024 Direct Common Stock
Stock Option (right to buy) 45,140 Mar 12, 2024 Direct Common Stock

Transactions reported by Neil Kumar for BridgeBio Pharma, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership